Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 9, 2000, Pages 1059-1063

  Rodrigues, V ^a,c   De Mello, F A ^a   Magalhaes E P ^a   Ribeiro, S B F ^b   Marquez, J O ^b  

^a Laboratories de Imunologia   (Brazil)

^b FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^c Faculdade Med do Triangulo Mineiro   (Brazil)

Author keywords

Cerebrospinal fluid; Cysticercosis; Cytokines

Indexed keywords

TAENIA SOLIUM;

CYTOKINE; GAMMA INTERFERON; HELMINTH ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CYSTICERCUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; NEUROCYSTICERCOSIS;

ANIMALS; ANTIBODIES, HELMINTH; CASE-CONTROL STUDIES; CYSTICERCUS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-5; NEUROCYSTICERCOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034264521     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2000000900011     Document Type: Article

References (20)

1. Ahuja GK, Roy S, Karla G & Vermin V (1978). Cerebral cysticercosis. Journal of the Neurological Sciences, 35: 365-374.
2. Del Bruto OH & Sotelo J (1988). Neurocysticercosis: an update. Review of Infectious Diseases, 10: 1075-1087.
3. White Jr AC (1997). Cysticercosis: a major cause of neurological disease worldwide. Clinical Infectious Diseases, 24: 10-15.
4. Silva-Vergara ML, Prata A, Netto HV, Vieira C de O, Castro JH, Micheletti LG, Otano AS & Franquini Junior J (1998). Risk factors associated with taeniasis-cysticercosis in Lagamar, Minas Gerais State, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 31: 65-71.
5. Monteiro L, Coelho T & Stocker A (1992). Neurocysticercosis - A review of 231 cases. Infection, 20: 61-65.
6. Rosenfeld EA, Byrd SE & Shulman ST (1996). Neurocysticercosis among children in Chicago. Clinical Infectious Diseases, 23: 262-268.
7. Pittella JEH (1997). Neuroysticercosis. Brain Pathology, 7: 681-693.
8. Miller BL, Staugaitis SM, Tourtellotte WW, Shapshak P, Goldberg M, Heiner D & Weil M (1985). Intra-blood-brain barrier IgG synthesis in cerebral cysticercosis. Archives of Neurology, 42: 782-784.
9. Restrepo BI, Llaguno P, Sandoval MA, Enciso JA & Teale JM (1998) Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. Journal of Neuroimmunology, 89: 64-72.
10. Cardona, AE, Restrepo BI, Jaramillo JM & Teale JM (1999). Development of an animal model for neurocysticercosis: Immune response in the central nervous system is characterized by a predominance of γδ T cells. Journal of Immunology, 162: 995-1002.
11. Robinson P, Atmar RL, Lewis DE & White Jr AC (1997). Granuloma cytokines in murine cysticercosis. Infection and Immunity, 65: 2925-2931.
12. Evans CA, Garcia HH, Hartnell A, Gilman RH, Jose PJ, Martinez M, Remick DG, Williams TJ & Friedland JS (1998). Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infection and Immunity, 66: 4522-4525.
13. Takatsu K, Takaki S & Hitoshi Y (1994). Interleukin-5 and its receptor system: implications in the immune system and inflammation. Advances in Immunology, 57: 145-190.
14. Moore KW, O'Garra A, de Vaal Malefyt R, Vieira P & Mosmann TR (1993). Interleukin-10. Annual Review of Immunology, 11: 165-190.
15. Finkelman FD, Holmes J, Katona IM, Urban Jr JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR & Paul WE (1990). Lymphokine control of in vivo immunoglobulin isotype selection. Annual Review of Immunology, 8: 303-333.
16. Sotelo JMD, Guerrero V & Rubio F (1985). Neurocysticercosis: a new classification based on active and inactive forms: A study of 753 cases. Archives of Internal Medicine, 145: 442-445.
17. Ridaura Sanz C (1987). Host response in childhood neurocysticercosis. Childs Nervous System, 3: 206-207.
18. Gutierrez Y (1990). Cysticercosis, coenurosis, and sparganosis. In: Gutierrez Y (Editor) Diagnostic Pathology of Parasitic Infection with Clinical Correlation Lea & Febiger, Philadelphia, 432-459
19. Ostrosky-Zeichner L, Mendonza EG, Rios C & Sotelo J (1996). Humoral and cellular immune response withir the subarachnoid space of patients with neurocysticercosis. Archives of Medical Research, 27: 513-517.
20. Butterworth AE, Strurrock RF, Houba V, Mohmoud AAF, Sher A & Rees PH (1975). Eosinophils as mediators of antibody-dependent damage to schistosomula in vitro. Nature, 26: 727-729.